Dr. Georges Netto is a pathologist practicing in Baltimore, MD. Dr. Netto is a doctor who specializes in the study of bodily fluids and tissues. As a pathologist, Dr. Netto can help your primary care doctor make a diagnosis about your medical condition. Dr. Netto may perform a tissue biopsy to determine if a patient has cancer, practice genetic testing, and complete a number of laboratory examinations. Pathologists can also perform autopsies which can determine a persons cause of death and gain information about genetic progression of a disease.
Education and Training
University Of Damascus Faculty Of Med Damascus Syria MD
University of Damascus / Faculty of Medicine 1985
- Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.
- Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and 'TUNEL' study.
- Diagnostic molecular pathology: an increasingly indispensable tool for the practicing pathologist.
- Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry.
- Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
- Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study.
- Fat-predominant mixed epithelial stromal tumor (MEST): report of a unique case mimicking angiomyolipoma.
- Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
- Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues.
- Aggressive recurrent respiratory papillomatosis in a neonate.
- Profiling the expression pattern of GPI transamidase complex subunits in human cancer.
- PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma.
- TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
- Phosphorylated H2AX in noninvasive low grade urothelial carcinoma of the bladder: correlation with tumor recurrence.
- Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy.
- The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma.
- TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.
- Editorial comment.
- Extracellular matrix associated protein CYR61 is linked to prostate cancer development.
- PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.
- Conventional prostatic adenocarcinoma arising in a multilocular prostatic
- Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
- Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.
- Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
- TMPRSS2-ERG fusion as a marker of prostatic lineage in small-cell carcinoma.
- Tumor volume threshold of insignificant prostate cancer--was Dr. Stamey right all along?
- Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.
- PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
- Adrenal lymphangioma: clinicopathologic and immunohistochemical characteristics of a rare lesion.
- ERG gene rearrangements are common in prostatic small cell carcinomas.
- Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases.
- Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid.
- An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.
- Molecular diagnostics in urologic malignancies: a work in progress.
- Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.
- Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: implications for novel intraoperative PSMA-based fluorescent imaging techniques.
- Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.
- Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
- Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.
- Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center.
- High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
- Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.
- Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas.
- Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
- DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma.
- Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma.
- Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
- Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: a pathological study of 139 lesions in 121 patients.
- High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy.
- Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
- High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues.
- Emerging critical role of molecular testing in diagnostic genitourinary pathology.
- Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas.
- Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases.
- GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.
- A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy.
- Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.
- Immunohistochemical evidence of dysregulation of the mammalian target of rapamycin pathway in primary and metastatic pheochromocytomas.
- Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum.
- Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder.
- Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen.
- High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pT1 urothelial carcinoma of the bladder: a tissue microarray study of 156 patients treated by transurethral r
- Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.
- Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
- Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses.
- Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer.
- Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
- Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole.
- Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas.
- Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate.
- Sacrococcygeal teratomas: clinico-pathological characteristics and isochromosome 12p status.
- The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
- Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
- The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases.
- Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network.
- TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
- Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
- Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases.
- Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage.
- Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.
- Molecular genetics and genomics progress in urothelial bladder cancer.
- t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.
- VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?
- Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
- Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy.
- Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.
- A Right Atrial Mass: "More Than Meets the Eye".
- An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.
- Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression.
- Pathological characteristics and radiographic correlates of complex renal cysts.
- Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection.
- High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
- ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.
- Utility of uroplakin II expression as a marker of urothelial carcinoma.
- Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
- Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
- Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.
- Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas.
- Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma.
- Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases.
- Smooth muscle and adenoma-like renal tumor: a previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?
- ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
- Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.
- Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
- Molecular Updates in Prostate Cancer.
- Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy.
- Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies.
- Molecular Pathology of Bladder Cancer.
- Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma.
- High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.
- Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
- Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
- The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.
- High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
- For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody.
- ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
- High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
- Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.
- Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
- Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective.
- Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases.
- MicroRNA expression profiling of Xp11 renal cell carcinoma.
- GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
- Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.
- Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.
- Preparing pathology for the molecular era.
- AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.
- MicroRNAs, promising biomarkers in the diagnosis of Xp11 translocation RCC-reply.
- miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
- INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell Tumors.
- Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
- PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability.
- Baylor Umc/Barnes Hosp, Meml Sloan Kettering Cancer Ctr
Dr. Georges Jabbourne Netto M.D.'s Practice location
Dr. Georges Jabbourne Netto M.D.'s reviewsWrite Review
- Is Shingles Contagious? How Do You Get Shingles?
Shingles is a contagious viral infection that is caused by the varicella zoster virus, the same virus that causes chickenpox. This virus affects a particular nerve section, causing painful rashes on the skin connected to that particular nerve. The rash normally appears in a form of a band on any...
- Mononucleosis: Am I Contagious Throughout the Duration of My Condition?
Mononucleosis is a disease that is spread through the Epstein-Barr virus. Specific details about the virus is still unknown. This virus is known to exhibit fatigue in people, accompanied by an aching body, swollen lymph nodes, and fever. This disease is known to be spread through saliva and other...
- Are There Vaccines Available For Cholera?
What Is Cholera?Cholera is an infectious disease that affects mostly the intestines, but causes complications to the rest of the body. Once a person suffers from cholera, the first parts of the body to be affected are the intestines. It is an infection caused by a bacteria known as the Vibrio...
- How to Prepare for a Biopsy
A biopsy procedure is a very important procedure, which is used to identify the underlying cause of your abnormal body tissues. Depending on your condition and the location of the tissue abnormality, different types of biopsies may be performed on you. A biopsy preparation, therefore, depends on...
- Treatments for Bladder Cancer
The treatment options or medications for bladder cancer depend largely on the advancement of cancer. The treatment is different for the early stage non-invasive bladder cancer and the more advanced muscle-invasive bladder cancer.During treatment, all hospitals have multidisciplinary teams (MDTs),...
- 5 Tips on Living with Mononucleosis
People with the mononucleosis (or mono) infection can live perfectly normal lives by doing what is best for them during their period of affliction. In this review, I have outlined the most essential tips on living with mononucleosis. In choosing these tips, the emphasis was focused on the well-being...
- Gruschenka N. Mojica Baltimore Maryland 21224
- Dr. Rania Hassan Younis BDS,MDS,PHD650 W Baltimore St Baltimore MD 21201
- Dr. Jean M Colandrea M.D.3455 Wilkens Ave Baltimore MD 21229
- Dr. Christian H Hansen M.D.3455 Wilkens Ave Baltimore MD 21229
- Dr. Andrea Proctor Subhawong MDJohns Hopkins Medical Institutions Dept Of Patholo Baltimore MD 21287
- Dr. William Westra M.D.1800 Orleans St Baltimore MD 21287